# Rivaara Labs Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rivaara-labs-private

- Industry: Healthcare
- Headquarters: Mumbai, India
- Website: www.rivaaralabs.com
- Total disclosed funding: $6.1M
- Latest round: Series A (Oct 14, 2022)
- Investors on record: 2

## About

Founded in 2019 by Syd Daftary, and based in Maharashtra, India, Rivaara Labs Private Limited, operates as a provider of molecular diagnostic lab services that use point-of-care technology for doctors and patients. In November 2022, Rivaara Labs Private Limited, raised INR 600 million in venture funding, co-led by investors Amicus Capital and Kotak Investment Advisors, with participation from the company's management.

The company provides molecular diagnostics labs that offer a wide range of test services. The company also provides bacterial diagnostic solutions using technologies based on DNA, molecular analysis, and RT-PCR technology. It uses point-of-care systems from companies like SphingoTec, JoinStar, and many more that offer point-of-care solutions for real-time, lab results.

The company plans to use the November 2022 funding to expand its lab network, update production facilities, accelerate its development, promote test kits, and hire new talent across India.

## Funding rounds

- Series A, Oct 14, 2022, $6.1M — Kotak Alternate Asset Managers, Amicus Capital

## Investors

- Kotak Alternate Asset Managers (https://capitalatlas.ai/funds/kotak-alternate-asset-managers) — Series A
- Amicus Capital — Series A